narciclasine has been researched along with dihydronarciclasine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ducki, S; Eastham, SA; Melody, N; Pettit, GR | 1 |
| Crankshaw, DJ; Holloway, AC; Makaji, E; McNulty, J; Nair, JJ; Pandey, S; Thorat, A; Vurgun, N | 1 |
2 other study(ies) available for narciclasine and dihydronarciclasine
| Article | Year |
|---|---|
Antineoplastic agents. 454. Synthesis of the strong cancer cell growth inhibitors trans-dihydronarciclasine and 7-deoxy-trans-dihydronarciclasine (1a).
Topics: Alkaloids; Amaryllidaceae Alkaloids; Antineoplastic Agents, Phytogenic; Catalysis; Isoquinolines; Molecular Structure; Narcissus; Palladium; Phenanthridines; Plants, Medicinal; Stereoisomerism | 2009 |
Human cytochrome P450 liability studies of trans-dihydronarciclasine: a readily available, potent, and selective cancer cell growth inhibitor.
Topics: Alkaloids; Amaryllidaceae Alkaloids; Antineoplastic Agents, Phytogenic; Crystallography, X-Ray; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Narcissus; Phenanthridines; Stereoisomerism | 2011 |